メディカルフーズ市場規模・シェア・トレンド分析レポート：投与経路別（経口・経腸）、製品別（錠剤・粉末・液体）、用途別、販売チャネル別、セグメント別予測、2022年～2030年

Medical Foods Market Size, Share & Trends Analysis Report By Route of Administration (Oral, Enteral), By Product (Pills, Powder, Liquid), By Application, By Sales Channel, And Segment Forecasts, 2022 - 2030

メディカルフーズ市場の成長と動向 Grand View Research, Inc.の最新レポートによると、世界の医療用食品市場規模は2030年までに335億米ドルに達する見込みです。2022年から2030年までのCAGRは5.2%で拡大する... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Grand View Research グランドビューリサーチ	2022年1月31日	US$5,950 シングルユーザーライセンスライセンス・価格情報注文方法はこちら	150	英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

メディカルフーズ市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の医療用食品市場規模は2030年までに335億米ドルに達する見込みです。2022年から2030年までのCAGRは5.2%で拡大すると予想されています。慢性疾患の罹患率の増加、高齢者人口の増加、栄養不良による負担の増大などが、長年にわたる市場の大幅な成長の主な要因となっています。例えば、WHOの報告書によると、2020年には約1億4,900万人の5歳未満の子どもが栄養不足により発育不良となり、3,890万人が肥満または過体重になるとされています。また、政策立案者が慢性疾患や栄養不足の管理に注力するようになったことも、医療用食品の導入を促進する要因と考えられます。

2021年には、経口投与のセグメントが65.0%以上の売上シェアを占め、市場を支配しています。このセグメントの成長に寄与している主な要因としては、経口投与された製品の消費のしやすさと高い商品性により、経口医療食品が好まれていることが挙げられます。また、これらの食品は、錠剤、粉末、プリン、増量済み製品など、さまざまな形態で入手できるため、このセグメントの成長を促進しています。

2021年には、粉末製品のセグメントが35.0%以上の最大の収益シェアを占めています。成長の要因としては、粉末医療食品の適用分野の増加、投与の容易さ、商業的実現性の高さなどが挙げられます。液体製品セグメントは、小児や高齢者が特別な医療目的で液体食品を容易に摂取できることから、予測期間中に最も速いペースで成長すると予想されています。

2021年には、化学療法による下痢の分野が最大のアプリケーション分野として浮上しました。化学療法治療による下痢は、がん患者に共通する問題の一つであり、がんの罹患率の上昇は、売上シェアを拡大する大きな理由の一つです。例えば、米国国立がん研究所の統計によると、化学療法剤による治療を受けると患者の約半数が下痢を発症し、特定の化学療法剤に関してはその割合が80％に達することもあります。

2021年の市場では、機関投資家向けの販売チャネルのセグメントが支配的でした。クリニック、病院、ケアセンターなどの医療機関における経口・経腸医療用食品の普及率と採用率の高さ、およびこれらの製品の消費量の増加が、大きな収益シェアを占める主な要因の一つです。また、入院施設での需要の高まりや、これらの製品の採用が増加していることも、市場の成長を後押ししています。

北米は、2021年に30.0%以上の収益シェアを獲得し、市場を支配しています。北米地域における大手企業の存在と、その企業が生み出す高い収益が、同地域の市場成長に寄与する主な要因となっています。加えて、戦略的な開発、慢性疾患の有病率の増加、患者や医療従事者による医療用食品の採用の増加なども成長を支える要因となっています。

さらに、COVID-19パンデミックの発生が続いていることから、医療用食品の消費が増加しています。医療従事者が、合併症や慢性疾患を抱える患者に医療用食品を摂取させる傾向が強まっていることも、市場の成長を支える要因となっています。また、COVID-19に起因する慢性疾患を抱える患者の合併症が増加していることから、これらの製品の導入と消費が促進され、市場の成長を支えています。

メディカルフーズ市場レポートハイライト

- 2021年には、経口投与のセグメントが市場を支配しました。このセグメントのシェアが高い主な要因は、経口投与された製品の消費のしやすさと高い商業的実現性のために、経口医療食品が好まれていることです

- 2021年には、粉末製品セグメントが最大の売上シェアを占めました。これは、粉末医療食品の適用分野の拡大、投与の容易さ、高い商品性などの要因によるものです。

- 2021年には、化学療法による下痢が主要なアプリケーションセグメントとして浮上した。予測期間中、糖尿病性神経障害の分野が最も速い成長率を示すと予想される

- 販売チャネル別では、診療所、病院、ケアセンターなどの医療機関での普及率が高いことから、2021年には施設販売セグメントが最大の売上シェアを占めました。

- 慢性疾患の増加と主要企業の存在により、2021年には北米が最大の売上シェアを占めた

ページTOPに戻る

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased database:
1.3.1.2 GVR’s internal database
1.3.2 Primary Research:
1.4 Research Scope and Assumptions
1.5 List to Data Sources
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Global Medical Foods Snapshot
Chapter 3 Global Medical Foods Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2. Related/ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Pricing Analysis
3.4 User Perspective Analysis
3.4.1 Consumer behavior analysis
3.4.2 Market influencer analysis
3.5 Technology Outlook
3.5.1 Technology timeline
3.6 Regulatory Framework
3.6.1 Reimbursement framework
3.6.2 Standards and compliances
3.7 Market Dynamics
3.7.1 Market driver analysis
3.7.2 Market restraint analysis
3.7.3. Industry Challenges
3.8 Medical Foods Market Analysis Tools
3.8.1. Industry Analysis - Porter’s
3.8.1.1 Supplier power
3.8.1.2 Buyer power
3.8.1.3 Substitution threat
3.8.1.4 Threat from new entrant
3.8.1.5 Competitive rivalry
3.8.2. PESTEL analysis
3.8.2.1 Political landscape
3.8.2.2 Environmental landscape
3.8.2.3 Social landscape
3.8.2.4 Technology landscape
3.8.2.5 Legal landscape
3.8.2.6 Economic landscape
3.8.3 Major deals & strategic alliances analysis
3.8.3.1 Mergers & acquisitions
3.8.3.2 Licensing & partnership
3.8.4 Market entry strategies
3.8 COVID-19 Impact on the market
Chapter 4 Medical Foods Market-Competitive Analysis
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.2 Competition Categorization
4.3 Vendor Landscape
4.3.1 List of Key Distributors and Channel Partners
4.3.2 Key Company Market Share Analysis, 2021
4.4 Public Companies
4.4.1 Company Market Position Analysis
4.4.2 Company Market Ranking, By Region
4.5 Private Companies
4.5.1 Regional Network Map
4.5.2 Company Market Position Analysis
Chapter 5 Medical Foods Market: Route of Administration Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Global Medical Foods Market: Route of Administration Market Share Analysis, 2021 and 2030
5.3 Oral
5.3.1 Oral market estimates and forecasts, 2016 - 2030 (USD million)
5.4 Enteral
5.4.1 Enteral market estimates and forecasts, 2016 - 2030 (USD million)
Chapter 6 Medical Foods Market: Product Estimates & Trend Analysis
6.1 Definitions & Scope
6.2 Global Medical Foods Market: Product Market Share Analysis, 2021 and 2030
6.3 Pills
6.3.1 Pills market estimates and forecasts, 2016 - 2030 (USD million)
6.4 Powders
6.4.1 Powders market estimates and forecasts, 2016 - 2030 (USD million)
6.5 Liquid
6.5.1 Liquid market estimates and forecasts, 2016 - 2030 (USD million)
6.6 Others
6.6.1 Others market estimates and forecasts, 2016 - 2030 (USD million)
Chapter 7 Medical Foods Market: Application Estimates & Trend Analysis
7.1 Definitions & Scope
7.2 Global Medical Foods Market: Application Market Share Analysis, 2021 and 2030
7.3 Chronic kidney diseases
7.3.1 Chronic kidney diseases market estimates and forecasts, 2016 - 2030 (USD million)
7.4 Minimal hepatic encephalopathy
7.4.1 Minimal hepatic encephalopathy market estimates and forecasts, 2016 - 2030 (USD million)
7.5 Chemotherapy-induced diarrhea
7.5.1 Chemotherapy-induced diarrhea market estimates and forecasts, 2016 - 2030 (USD million)
7.6 Pathogen related infections
7.6.1 Pathogen related infections market estimates and forecasts, 2016 - 2030 (USD million)
7.7 Diabetic neuropathy
7.7.1 Diabetic neuropathy market estimates and forecasts, 2016 - 2030 (USD million)
7.8 ADHD
7.8.1 ADHD market estimates and forecasts, 2016 - 2030 (USD million)
7.9 Depression
7.9.1 Depression market estimates and forecasts, 2016 - 2030 (USD million)
7.10 Alzheimer’s disease
7.10.1 Alzheimer’s disease market estimates and forecasts, 2016 - 2030 (USD million)
7.11 Nutritional deficiency
7.11.1 Nutritional deficiency market estimates and forecasts, 2016 - 2030 (USD million)
7.12 Orphan diseases
7.12.1 Orphan diseases market estimates and forecasts, 2016 - 2030 (USD million)
7.12.2 Phenylketonuria
7.12.2.1 Phenylketonuria market estimates and forecasts, 2016 - 2030 (USD million)
7.12.3 Eosinophilic esophagitis
7.12.3.1 Eosinophilic esophagitis market estimates and forecasts, 2016 - 2030 (USD million)
7.12.4 FPIES
7.12.4.1 FPIES market estimates and forecasts, 2016 - 2030 (USD million)
7.12.5 Tyrosinemia
7.12.5.1 Tyrosinemia market estimates and forecasts, 2016 - 2030 (USD million)
7.12.6 MSUD
7.12.6.1 MSUD market estimates and forecasts, 2016 - 2030 (USD million)
7.12.7 Homocystinuria
7.12.7.1 Homocystinuria market estimates and forecasts, 2016 - 2030 (USD million)
7.12.8 Others
7.12.8.1 Others market estimates and forecasts, 2016 - 2030 (USD million)
7.13 Wound Healing
7.13.1 Wound Healing applications market estimates and forecasts, 2016 - 2030 (USD million)
7.14 Chronic Diarrhea
7.14.1 Chronic Diarrhea applications market estimates and forecasts, 2016 - 2030 (USD million)
7.15 Constipation Relief
7.15.1 Constipation Relief applications market estimates and forecasts, 2016 - 2030 (USD million)
7.16 Protein Booster
7.16.1 Protein Booster applications market estimates and forecasts, 2016 - 2030 (USD million)
7.17 Dysphagia
7.17.1 Dysphagia applications market estimates and forecasts, 2016 - 2030 (USD million)
7.18 Pain Management
7.18.1 Pain Management applications market estimates and forecasts, 2016 - 2030 (USD million)
7.19 Parkinson's Disease
7.19.1 Parkinson's Disease applications market estimates and forecasts, 2016 - 2030 (USD million)
7.20 Epilepsy
7.20.1 Epilepsy applications market estimates and forecasts, 2016 - 2030 (USD million)
7.21 Other Cancer related treatments
7.21.1 Other Cancer related treatments applications market estimates and forecasts, 2016 - 2030 (USD million)
7.22 Severe protein allergy
7.22.1 Wound Healing applications market estimates and forecasts, 2016 - 2030 (USD million)
7.23 Others
7.23.1 Others applications market estimates and forecasts, 2016 - 2030 (USD million)
Chapter 8 Medical Foods Market: Sales Channel Estimates & Trend Analysis
8.1 Definitions & Scope
8.2 Global Medical Foods Market: Sales Channel Market Share Analysis, 2021 and 2030
8.3 Online sales
8.3.1 Online sales market estimates and forecasts, 2016 - 2030 (USD million)
8.4 Institutional sales
8.4.1 Institutional sales market estimates and forecasts, 2016 - 2030 (USD million)
8.5 Retail sales
8.5.1 Retail sales market estimates and forecasts, 2016 - 2030 (USD million)
Chapter 9 Medical Foods Market: Regional Estimates & Trend Analysis, By Route of Administration, Product, Application, and Sales Channel
9.1 Global Medical Foods Market: Regional Movement Analysis
9.2 North America
9.2.1 North America medical foods market estimates and forecasts by route of administration, Product, application, and sales channel (USD Million), 2016 - 2030
9.2.2 U.S.
9.2.2.1 U.S. medical foods market estimates and forecasts by route of administration, Product, application, and sales channel (USD Million), 2016 - 2030
9.2.3 Canada
9.2.3.1 Canada medical foods market estimates and forecasts by route of administration, Product, application, and sales channel (USD Million), 2016 - 2030
9.3 Europe
9.3.1 Europe Medical Fo medical foods ods market estimates and forecasts by route of administration, Product, application, and sales channel (USD Million), 2016 - 2030
9.3.2 U.K.
9.3.2.1 U.K. medical foods market estimates and forecasts by route of administration, Product, application, and sales channel (USD Million), 2016 - 2030
9.3.3 Germany
9.3.3.1 Germany medical foods market estimates and forecasts by route of administration, Product, application, and sales channel (USD Million), 2016 - 2030
9.3.4 France
9.3.4.1 France medical foods market estimates and forecasts by route of administration, Product, application, and sales channel (USD Million), 2016 - 2030
9.3.5 Spain
9.3.5.1 Spain medical foods market estimates and forecasts by route of administration, Product, application, and sales channel (USD Million), 2016 - 2030
9.3.6 Italy
9.3.6.1 Italy medical foods market estimates and forecasts by route of administration, Product, application, and sales channel (USD Million), 2016 - 2030
9.3.7 Russia
9.3.7.1 Russia medical foods market estimates and forecasts by route of administration, Product, application, and sales channel (USD Million), 2016 - 2030
9.4 Asia Pacific
9.4.1 Asia pacific medical foods market estimates and forecasts by route of administration, product, application, and sales channel (USD Million), 2016 - 2030
9.4.2 China
9.4.2.1 China medical foods market estimates and forecasts by route of administration, product, application, and sales channel (USD Million), 2016 - 2030
9.4.3 Japan
9.4.3.1 Japan medical foods market estimates and forecasts by route of administration, product, application, and sales channel (USD Million), 2016 - 2030
9.4.4 India
9.4.4.1 India medical foods market estimates and forecasts by route of administration, product, application, and sales channel (USD Million), 2016 - 2030
9.4.5 Australia
9.4.5.1 Australia medical foods market estimates and forecasts by route of administration, product, application, and sales channel (USD Million), 2016 - 2030
9.4.6 New Zealand
9.4.6.1 New Zealand medical foods market estimates and forecasts by route of administration, product, application, and sales channel (USD Million), 2016 - 2030
9.4.7 Singapore
9.4.7.1 Singapore medical foods market estimates and forecasts by route of administration, product, application, and sales channel (USD Million), 2016 - 2030
9.4.8 South Korea
9.4.8.1 South Korea medical foods market estimates and forecasts by route of administration, product, application, and sales channel (USD Million), 2016 - 2030
9.5 Latin America
9.5.1 Latin America medical foods market estimates and forecasts by route of administration, product, application, and sales channel (USD Million), 2016 - 2030
9.5.2 Brazil
9.5.2.1 Brazil medical foods market estimates and forecasts by route of administration, product, application, and sales channel (USD Million), 2016 - 2030
9.5.3 Mexico
9.5.3.1 Mexico medical foods market estimates and forecasts by route of administration, product, application, and sales channel (USD Million), 2016 - 2030
9.5.4 Argentina
9.5.4.1 Argentina medical foods market estimates and forecasts by route of administration, product, application, and sales channel (USD Million), 2016 - 2030
9.6 MEA
9.6.1 MEA medical foods market estimates and forecasts by route of administration, product, application, and sales channel (USD Million), 2016 - 2030
9.6.2 South Africa
9.6.2.1 South Africa medical foods market estimates and forecasts by route of administration, product, application, and sales channel (USD Million), 2016 - 2030
9.6.3 Saudi Arabia
9.6.3.1 Saudi Arabia medical foods market estimates and forecasts by route of administration, product, application, and sales channel (USD Million), 2016 - 2030
9.6.4 UAE
9.6.4.1 UAE medical foods market estimates and forecasts by route of administration, product, application, and sales channel (USD Million), 2016 - 2030
Chapter 10 Company Profiles
10.1 DANONE
10.1.1 Company overview
10.1.2 Financial performance
10.1.3 Product benchmarking
10.1.4 Strategic initiatives
10.2 NESTLE
10.2.1 Company overview
10.2.2 Financial performance
10.2.3 Product benchmarking
10.2.4 Strategic initiatives
10.3 ABBOTT
10.3.1 Company overview
10.3.2 Financial performance
10.3.3 Product benchmarking
10.3.4 Strategic initiatives
10.4 TARGETED MEDICAL PHARMA INC.
10.4.1 Company overview
10.4.2 Financial performance
10.4.3 Product benchmarking
10.4.4 Strategic initiatives
10.5 PRIMUS PHARMACEUTICALS, INC.
10.5.1 Company overview
10.5.2 Financial performance
10.5.3 Product benchmarking
10.5.4 Strategic initiatives
10.6 MEAD JOHNSON & COMPANY, LLC
10.6.1 Company overview
10.6.2 Financial performance
10.6.3 Product benchmarking
10.6.4 Strategic initiatives
10.7 FRESENIUS KABI AG
10.7.1 Company overview
10.7.2 Financial performance
10.7.3 Product benchmarking
10.7.4 Strategic initiatives
10.8 List of Other Companies

ページTOPに戻る

Table of Contents

Summary

Medical Foods Market Growth & Trends

The global medical foods market size is expected to reach USD 33.5 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% from 2022 to 2030. Increasing incidences of chronic diseases, the rising geriatric population, and the growing burden of malnutrition are the major factors responsible for the substantial growth of the market over the years. For instance, according to a WHO report, about 149 million children under 5 were stunted and 38.9 million were obese or overweight due to undernutrition in 2020. The emerging focus of the policymakers to manage chronic disorders and nutritional deficiency is also anticipated to drive the adoption of medical foods over the years.

The oral route of the administration segment dominated the market with a revenue share of over 65.0% in 2021. The major factors contributing to the segment growth include a high preference for oral medical foods owing to the ease of consumption and high commercial viability of products administered orally. In addition, these foods are available in a variety of forms such as pills, powder, puddings, and pre-thickened products, thereby fueling the growth of the segment.

In 2021, the powder product segment accounted for the largest revenue share of over 35.0%. Factors contributing to the growth are rising application areas of powdered medical foods, ease of administration, and higher commercial viability. The liquid segment is anticipated to grow at the fastest rate during the forecast period owing to the ease of consumption of liquid-based foods for special medical purposes by the pediatric and geriatric population.

The chemotherapy-induced diarrhea segment emerged as the largest application segment in 2021. Diarrhea caused by chemotherapy treatment is one of the common problems among cancer patients and the rising prevalence of cancer is one of the major reasons for increasing the revenue share. For instance, according to the National Cancer Institute statistics, about half of the patients develop diarrhea when treated with chemotherapy agents and the rate can reach 80% with respect to certain chemotherapy agents.

The institutional sales channel segment dominated the market in 2021. Higher penetration and adoption of oral and enteral medical foods in the healthcare institutions such as clinics, hospitals, and care centers and the rising consumption of these products are some of the major factors contributing to the large revenue share. In addition, rising demand for such products in inpatient facilities and increasing adoption for such products are boosting the market growth.

North America dominated the market with a revenue share of over 30.0% in 2021. The presence of major players and high revenue generated by them in the North American region are the key factors contributing to the regional market growth. In addition, strategic developments, the growing prevalence of chronic conditions, and the increasing adoption of medical foods by patients and healthcare professionals are the other factors supporting the growth.

Furthermore, the ongoing outbreak of the COVID-19 pandemic has led to an increase in the consumption of medical foods. Growing preference by healthcare professionals to consume these products in patients suffering from comorbidities and chronic conditions is beneficial in supporting the market growth. In addition, increasing complications in the patients suffering from chronic disorders due to COVID-19 disease are fueling their adoption and consumption, thereby supporting the growth.

Medical Foods Market Report Highlights

• The oral route of the administration segment dominated the market in 2021. The major factors contributing to the large share of the segment include a high preference for oral medical foods owing to the ease of consumption and high commercial viability of products administered orally

• The powder product segment accounted for the largest revenue share in 2021 owing to the factors such as rising application areas of powdered medical foods, ease of administration, and higher commercial viability

• Chemotherapy-induced diarrhea emerged as the leading application segment in 2021. The diabetic neuropathy segment is expected to register the fastest growth rate over the forecast period

• By sales channel, the institutional sales segment accounted for the largest revenue share in 2021 owing to the higher penetration and adoption of these products in the healthcare institutions such as clinics, hospitals, and care centers

• North America accounted for the largest revenue share in 2021 due to the increasing prevalence of chronic diseases and the presence of key players

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（通信回線）の最新刊レポート

Grand View Research 社の最新刊レポート

本レポートと同じKEY WORD（administration oral）の最新刊レポート

よくあるご質問

Grand View Research社はどのような調査会社ですか?

グランドビューリサーチ（Grand View Research）は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

メディカルフーズ市場規模・シェア・トレンド分析レポート：投与経路別（経口・経腸）、製品別（錠剤・粉末・液体）、用途別、販売チャネル別、セグメント別予測、2022年～2030年

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（通信回線）の最新刊レポート

Grand View Research 社の最新刊レポート

本レポートと同じKEY WORD（administration oral）の最新刊レポート

よくあるご質問

Grand View Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?